1021B |
Substituted Cathinone Panel, Blood |
1021SP |
Substituted Cathinone Panel, Serum/Plasma |
1021U |
Substituted Cathinone Panel, Urine |
1022B |
Eutylone, Blood |
1022SP |
Eutylone, Serum/Plasma |
1022U |
Eutylone (Qualitative), Urine |
1040B |
Cetirizine, Blood |
1040SP |
Cetirizine, Serum/Plasma |
1040U |
Cetirizine, Urine |
1190B |
Chlorpheniramine, Blood |
1190SP |
Chlorpheniramine, Serum/Plasma |
1190U |
Chlorpheniramine, Urine |
1348U |
Creatinine, Urine Overview: Evaluate Extent of Urine Dilution or Concentration |
1425B |
Cyproheptadine, Blood |
1425SP |
Cyproheptadine, Serum/Plasma |
1425U |
Cyproheptadine, Urine |
1480B |
Designer Opioids, Blood |
1480SP |
Designer Opioids, Serum/Plasma |
1480U |
Designer Opioids (Qualitative), Urine |
1483B |
Desalkylgidazepam, Blood |
1483SP |
Desalkylgidazepam, Serum/Plasma |
1483U |
Desalkylgidazepam (Qualitative), Urine |
1760B |
Diphenhydramine, Blood |
1760FL |
Diphenhydramine, Fluid |
1760SP |
Diphenhydramine, Serum/Plasma |
1760TI |
Diphenhydramine, Tissue |
1760U |
Diphenhydramine, Urine |
1817B |
Doxylamine, Blood |
1817FL |
Doxylamine, Fluid |
1817SP |
Doxylamine, Serum/Plasma |
1817TI |
Doxylamine, Tissue |
1817U |
Doxylamine, Urine |